Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 8—August 2007

Streptococcus sinensis Endocarditis outside Hong Kong

Ilker Uçkay*Comments to Author , Peter Rohner*, Ignacio Bolivar†, Béatrice Ninet*, Marina Djordjevic*, Vandack Nobre*, Christian Garzoni*, and Jacques Schrenzel*
Author affiliations: *University Hospitals of Geneva, Geneva, Switzerland; †Institut für Angewandte Immunologie, Zuchwil, Switzerland;

Main Article


Susceptibility of Streptococcus sinensis–related strain from University Hospitals of Geneva

Antimicrobial agent MIC (mg/L) Interpretation
Penicillin 0.064 Susceptible
Ceftriaxone 0.19 Susceptible
Imipenem 0.064 Susceptible
Gentamicin 3 Intermediate resistant
Levofloxacin 1 Susceptible
Clindamycin 0.094 Susceptible
Erythromycin 0.047 Susceptible
Rifampicin 0.032 Susceptible
Cotrimoxazole 1 Susceptible
Tetracycline 0.125 Susceptible
Tigecycline 0.064 Susceptible
Linezolid 0.5 Susceptible
Vancomycin 1 Susceptible
Teicoplanin 0.25 Susceptible

Main Article

Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.